Differential behaviour of epicardial adipose tissue-secretomes with high and low orosomucoid levels from patients with cardiovascular disease in H9C2 cells

Molecular and Cellular Endocrinology

Volumn 416, Issue , 2015, Pages 77-87

  Lage, Ricardo ^a,b   Moscoso, Isabel ^a,b   Fernández Trasancos, Ángel ^a   Cebro, María ^b   Couselo, Marinela ^b   Fandiño Vaquero, Rubén ^b   Bravo, Susana B ^b   Sierra, Juan ^b   González Juanatey, José Ramón ^a,b   Eiras, Sonia ^a  

^a Santiago University Clinical Hospital   (Spain)

^b Instituto de Salud Carlos III   (Spain)

Author keywords

Epicardial fat; H9C2 cells; Orosomucoid; Secretome

Indexed keywords

CASPASE 3; FATTY ACID; OROSOMUCOID; SECRETOME; SECRETORY PROTEIN; UNCLASSIFIED DRUG; LIPOCORTIN 5;

ADIPOSE TISSUE; AGED; ANIMAL CELL; APOPTOSIS; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPICARDIAL ADIPOSE TISSUE; EPICARDIUM; FEMALE; FLOW CYTOMETRY; HEART MUSCLE CELL; HUMAN; HUMAN TISSUE; HYPOXIA; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MYOBLAST; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; WESTERN BLOTTING; ANIMAL; CARDIAC MYOBLAST; CELL HYPOXIA; CELL LINE; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PERICARDIUM; VERY ELDERLY;

ADIPOSE TISSUE; AGED; AGED, 80 AND OVER; ANIMALS; ANIMALS, NEWBORN; ANNEXIN A5; APOPTOSIS; CARDIOVASCULAR DISEASES; CASPASE 3; CELL HYPOXIA; CELL LINE; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; MYOBLASTS, CARDIAC; OROSOMUCOID; PERICARDIUM; RATS;

EID: 84943660403     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2015.08.025     Document Type: Article

References (63)

1. Birnbaum Y., Long B., Qian J., Perez-Polo J.R., Ye Y. Pioglitazone limits myocardial infarct size, activates Akt, and upregulates cPLA2 and COX-2 in a PPAR-gamma-independent manner. Basic Res. Cardiol. 2011, 106:431-446.
2. Bonzon-Kulichenko E., Perez-Hernandez D., Nunez E., Martinez-Acedo P., Navarro P., Trevisan-Herraz M., Ramos M.d.C., Sierra S., Martinez-Martinez S., Ruiz-Meana M., Miro-Casas E., Garcia-Dorado D., Redondo J.M., Burgos J.S., Vazquez J. A robust method for quantitative high-throughput analysis of proteomes by 18O labeling. Mol. Cell. Proteom. 2011, 10. M110.003335.
3. Bories P.N., Guenounou M., Feger J., Kodari E., Agneray J., Durand G. Human alpha 1-acid glycoprotein-exposed macrophages release interleukin 1 inhibitory activity. Biochem. Biophys. Res. Commun. 1987, 147:710-715.
4. Ceciliani F., Pocacqua V., Miranda-Ribera A., Bronzo V., Lecchi C., Sartorelli P. Alpha(1)-Acid glycoprotein modulates apoptosis in bovine monocytes. Vet. Immunol. Immunopathol. 2007, 116:145-152.
5. Chabowski A., Gorski J., Calles-Escandon J., Tandon N.N., Bonen A. Hypoxia-induced fatty acid transporter translocation increases fatty acid transport and contributes to lipid accumulation in the heart. FEBS Lett. 2006, 580:3617-3623.
6. Chao T.F., Hung C.L., Tsao H.M., Lin Y.J., Yun C.H., Lai Y.H., Chang S.L., Lo L.W., Hu Y.F., Tuan T.C., Chang H.Y., Kuo J.Y., Yeh H.I., Wu T.J., Hsieh M.H., Yu W.C., Chen S.A. Epicardial adipose tissue thickness and ablation outcome of atrial fibrillation. PLoS One 2013, 8:e74926.
7. de Vries J.E., Vork M.M., Roemen T.H., de Jong Y.F., Cleutjens J.P., van der Vusse G.J., van Bilsen M. Saturated but not mono-unsaturated fatty acids induce apoptotic cell death in neonatal rat ventricular myocytes. J. Lipid Res. 1997, 38:1384-1394.
8. Doesch C., Haghi D., Fluchter S., Suselbeck T., Schoenberg S.O., Michaely H., Borggrefe M., Papavassiliu T. Epicardial adipose tissue in patients with heart failure. J. Cardiovasc Magn. Reson. 2010, 12:40.
9. Drosatos K., Schulze P.C. Cardiac lipotoxicity: molecular pathways and therapeutic implications. Curr. Heart Fail Rep. 2013, 10:109-121.
10. Engstrom G., Lind P., Hedblad B., Stavenow L., Janzon L., Lindgarde F. Effects of cholesterol and inflammation-sensitive plasma proteins on incidence of myocardial infarction and stroke in men. Circulation 2002, 105:2632-2637.
11. Engstrom G., Hedblad B., Tyden P., Lindgarde F. Inflammation-sensitive plasma proteins are associated with increased incidence of heart failure: a population-based cohort study. Atherosclerosis 2009, 202:617-622.
12. Eroglu S., Sade L.E., Yildirir A., Bal U., Ozbicer S., Ozgul A.S., Bozbas H., Aydinalp A., Muderrisoglu H. Epicardial adipose tissue thickness by echocardiography is a marker for the presence and severity of coronary artery disease. Nutr. Metab. Cardiovasc Dis. 2009, 19:211-217.
13. Fain J.N., Sacks H.S., Buehrer B., Bahouth S.W., Garrett E., Wolf R.Y., Carter R.A., Tichansky D.S., Madan A.K. Identification of omentin mRNA in human epicardial adipose tissue: comparison to omentin in subcutaneous, internal mammary artery periadventitial and visceral abdominal depots. Int. J. Obes. (Lond) 2008, 32:810-815.
14. Fandino-Vaquero R., Fernandez-Trasancos A., Alvarez E., Ahmad S., Batista-Oliveira A.L., Adrio B., Fernandez A.L., Gonzalez-Juanatey J.R., Eiras S. Orosomucoid secretion levels by epicardial adipose tissue as possible indicator of endothelial dysfunction in diabetes mellitus or inflammation in coronary artery disease. Atherosclerosis 2014, 235:281-288.
15. Fournier T., Medjoubi N.N., Porquet D. Alpha-1-acid glycoprotein. Biochim. Biophys. Acta 2000, 1482:157-171.
16. Frantz S., Kobzik L., Kim Y.D., Fukazawa R., Medzhitov R., Lee R.T., Kelly R.A. Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium. J. Clin. Invest. 1999, 104:271-280.
17. Galvez-Monton C., Prat-Vidal C., Roura S., Farre J., Soler-Botija C., Llucia-Valldeperas A., Diaz-Guemes I., Sanchez-Margallo F.M., Aris A., Bayes-Genis A. Transposition of a pericardial-derived vascular adipose flap for myocardial salvage after infarct. Cardiovasc. Res. 2011, 91:659-667.
18. Greulich S., Maxhera B., Vandenplas G., Herzfeld de Wiza D., Smiris K., Mueller H., Heinrichs J., Blumensatt M., Cuvelier C., Akhyari P., Ruige J.B., Ouwens D.M., Eckel J. Secretory products from epicardial adipose tissue of patients with type 2 diabetes induce cardiomyocyte dysfunction. Circulation 2012, 126:2324-2334.
19. Greulich S., Chen W.J., Maxhera B., Rijzewijk L.J., van der Meer R.W., Jonker J.T., Mueller H., de Wiza D.H., Floerke R.R., Smiris K., Lamb H.J., de Roos A., Bax J.J., Romijn J.A., Smit J.W., Akhyari P., Lichtenberg A., Eckel J., Diamant M., Ouwens D.M. Cardioprotective properties of omentin-1 in type 2 diabetes: evidence from clinical and in vitro studies. PLoS One 2013, 8:e59697.
20. Heliovaara M.K., Herz M., Teppo A.M., Leinonen E., Ebeling P. Pioglitazone has anti-inflammatory effects in patients with Type 2 diabetes. J. Endocrinol. Invest. 2007, 30:292-297.
21. Hescheler J., Meyer R., Plant S., Krautwurst D., Rosenthal W., Schultz G. Morphological, biochemical, and electrophysiological characterization of a clonal cell (H9c2) line from rat heart. Circ. Res. 1991, 69:1476-1486.
22. Hua F., Ha T., Ma J., Li Y., Kelley J., Gao X., Browder I.W., Kao R.L., Williams D.L., Li C. Protection against myocardial ischemia/reperfusion injury in TLR4-deficient mice is mediated through a phosphoinositide 3-kinase-dependent mechanism. J. Immunol. 2007, 178:7317-7324.
23. Iacobellis G., Bianco A.C. Epicardial adipose tissue: emerging physiological, pathophysiological and clinical features. Trends Endocrinol. Metab. 2011, 22:450-457.
24. Iacobellis G., Leonetti F. Epicardial adipose tissue and insulin resistance in obese subjects. J. Clin. Endocrinol. Metab. 2005, 90:6300-6302.
25. Kagaya N., Kamiyoshi A., Tagawa Y., Akamatsu S., Isoda K., Kawase M., Yagi K. Suppression of cell death in primary rat hepatocytes by alpha1-acid glycoprotein. J. Biosci. Bioeng. 2005, 99:81-83.
26. Karastergiou K., Evans I., Ogston N., Miheisi N., Nair D., Kaski J.C., Jahangiri M., Mohamed-Ali V. Epicardial adipokines in obesity and coronary artery disease induce atherogenic changes in monocytes and endothelial cells. Arterioscler. Thromb. Vasc. Biol. 2010, 30:1340-1346.
27. Kataoka Y., Shibata R., Ohashi K., Kambara T., Enomoto T., Uemura Y., Ogura Y., Yuasa D., Matsuo K., Nagata T., Oba T., Yasukawa H., Numaguchi Y., Sone T., Murohara T., Ouchi N. Omentin prevents myocardial ischemic injury through AMP-activated protein kinase- and Akt-dependent mechanisms. J. Am. Coll. Cardiol. 2014, 63:2722-2733.
28. Khawaja T., Greer C., Chokshi A., Chavarria N., Thadani S., Jones M., Schaefle K., Bhatia K., Collado J.E., Shimbo D., Einstein A.J., Schulze P.C. Epicardial fat volume in patients with left ventricular systolic dysfunction. Am. J. Cardiol. 2011, 108:397-401.
29. Komori H., Watanabe H., Shuto T., Kodama A., Maeda H., Watanabe K., Kai H., Otagiri M., Maruyama T. Alpha(1)-Acid glycoprotein up-regulates CD163 via TLR4/CD14 protein pathway: possible protection against hemolysis-induced oxidative stress. J. Biol. Chem. 2012, 287:30688-30700.
30. Kustermann S., Boess F., Buness A., Schmitz M., Watzele M., Weiser T., Singer T., Suter L., Roth A. A label-free, impedance-based real time assay to identify drug-induced toxicities and differentiate cytostatic from cytotoxic effects. Toxicol. In Vitro 2012, 27:1589-1595.
31. Kuznetsov A.V., Javadov S., Sickinger S., Frotschnig S., Grimm M. H9c2 and HL-1 cells demonstrate distinct features of energy metabolism, mitochondrial function and sensitivity to hypoxia-reoxygenation. Biochim. Biophys. Acta 2014, 1853:276-284.
32. Lee J.Y., Sohn K.H., Rhee S.H., Hwang D. Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. J. Biol. Chem. 2001, 276:16683-16689.
33. Lee J.Y., Ye J., Gao Z., Youn H.S., Lee W.H., Zhao L., Sizemore N., Hwang D.H. Reciprocal modulation of Toll-like receptor-4 signaling pathways involving MyD88 and phosphatidylinositol 3-kinase/AKT by saturated and polyunsaturated fatty acids. J. Biol. Chem. 2003, 278:37041-37051.
34. Lee Y.S., Choi J.W., Hwang I., Lee J.W., Lee J.H., Kim A.Y., Huh J.Y., Koh Y.J., Koh G.Y., Son H.J., Masuzaki H., Hotta K., Alfadda A.A., Kim J.B. Adipocytokine orosomucoid integrates inflammatory and metabolic signals to preserve energy homeostasis by resolving immoderate inflammation. J. Biol. Chem. 2010, 285:22174-22185.
35. Lee S.M., Choi S.E., Lee J.H., Lee J.J., Jung I.R., Lee S.J., Lee K.W., Kang Y. Involvement of the TLR4 (Toll-like receptor4) signaling pathway in palmitate-induced INS-1 beta cell death. Mol. Cell Biochem. 2011, 354:207-217.
36. Li A.Y., Yang Q., Yang K. miR-133a mediates the hypoxia-induced apoptosis by inhibiting TAGLN2 expression in cardiac myocytes. Mol. Cell Biochem. 2015, 400:173-181.
37. Liaunardy-Jopeace A., Gay N.J. Molecular and cellular regulation of toll-like receptor-4 activity induced by lipopolysaccharide ligands. Front. Immunol. 2014, 5:473.
38. Ligresti G., Aplin A.C., Dunn B.E., Morishita A., Nicosia R.F. The acute phase reactant orosomucoid-1 is a bimodal regulator of angiogenesis with time- and context-dependent inhibitory and stimulatory properties. PLoS One 2012, 7:e41387.
39. Liu S.Q., Tefft B.J., Roberts D.T., Zhang L.Q., Ren Y., Li Y.C., Huang Y., Zhang D., Phillips H.R., Wu Y.H. Cardioprotective proteins upregulated in the liver in response to experimental myocardial ischemia. Am. J. Physiol. Heart Circ. Physiol. 2012, 303:H1446-H1458.
40. Liu B.S., Xu F., Wang J.L., Zhang C., Zhang Y., Hao P.P., Chen Y.G. The cardioprotection of ischemic postconditioning in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Int. J. Cardiol. 2014, 178:181-183.
41. Mazurek T., Zhang L., Zalewski A., Mannion J.D., Diehl J.T., Arafat H., Sarov-Blat L., O'Brien S., Keiper E.A., Johnson A.G., Martin J., Goldstein B.J., Shi Y. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 2003, 108:2460-2466.
42. Moscoso I., Tejados N., Barreiro O., Sepulveda P., Izarra A., Calvo E., Dorronsoro A., Salcedo J.M., Sadaba R., Diez-Juan A., Trigueros C., Bernad A. Podocalyxin-like protein 1 is a relevant marker for human c-kit cardiac stem cells. J. Tissue Eng. Regen. Med. 2013, 10.1002/term.1795.
43. Muraguchi T., Kawawa A., Kubota S. Prohibitin protects against hypoxia-induced H9c2 cardiomyocyte cell death. Biomed. Res. 2010, 31:113-122.
44. Oliveros J.C. An Interactive Tool for Comparing Lists with Venn Diagrams 2007, VENNY.
45. Opie L.H. Metabolism of free fatty acids, glucose and catecholamines in acute myocardial infarction. Relation to myocardial ischemia and infarct size. Am. J. Cardiol. 1975, 36:938-953.
46. Perez-Hernandez D., Gutierrez-Vazquez C., Jorge I., Lopez-Martin S., Ursa A., Sanchez-Madrid F., Vazquez J., Yanez-Mo M. The intracellular interactome of tetraspanin-enriched microdomains reveals their function as sorting machineries toward exosomes. J. Biol. Chem. 2013, 288:11649-11661.
47. Rabkin S.W. Epicardial fat: properties, function and relationship to obesity. Obes. Rev. 2007, 8:253-261.
48. Rieger A.M., Nelson K.L., Konowalchuk J.D., Barreda D.R. Modified annexin V/propidium iodide apoptosis assay for accurate assessment of cell death. J. Vis. Exp. 2011, 50:2597.
49. Robertson H.F. The vascularization of the epicardial and periaortic fat pads. Am. J. Pathol. 1930, 6(2):209-215.
50. Sacks H.S., Fain J.N., Cheema P., Bahouth S.W., Garrett E., Wolf R.Y., Wolford D., Samaha J. Inflammatory genes in epicardial fat contiguous with coronary atherosclerosis in the metabolic syndrome and type 2 diabetes: changes associated with pioglitazone. Diabetes Care 2011, 34:730-733.
51. Salgado-Somoza A., Teijeira-Fernandez E., Fernandez A.L., Gonzalez-Juanatey J.R., Eiras S. Changes in lipid transport-involved proteins of epicardial adipose tissue associated with coronary artery disease. Atherosclerosis 2012, 224:492-499.
52. Shang F.J., Wang J.P., Liu X.T., Zheng Q.S., Xue Y.S., Wang B., Zhao L.Y. Serum omentin-1 levels are inversely associated with the presence and severity of coronary artery disease in patients with metabolic syndrome. Biomarkers 2011, 16:657-662.
53. Shevchenko A., Wilm M., Vorm O., Mann M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem. 1996, 68:850-858.
54. Sun N., Hao J.R., Li X.Y., Yin X.H., Zong Y.Y., Zhang G.Y., Gao C. GluR6-FasL-Trx2 mediates denitrosylation and activation of procaspase-3 in cerebral ischemia/reperfusion in rats. Cell Death Dis. 2013, 4:e771.
55. Tian H., Liu C., Zou X., Wu W., Zhang C., Yuan D. MiRNA-194 regulates palmitic acid-induced toll-like receptor 4 inflammatory responses in THP-1 cells. Nutrients 2015, 7:3483-3496.
56. Van Molle W., Libert C., Fiers W., Brouckaert P. Alpha 1-acid glycoprotein and alpha 1-antitrypsin inhibit TNF-induced but not anti-Fas-induced apoptosis of hepatocytes in mice. J. Immunol. 1997, 159:3555-3564.
57. Van Molle W., Denecker G., Rodriguez I., Brouckaert P., Vandenabeele P., Libert C. Activation of caspases in lethal experimental hepatitis and prevention by acute phase proteins. J. Immunol. 1999, 163:5235-5241.
58. Venteclef N., Guglielmi V., Balse E., Gaborit B., Cotillard A., Atassi F., Amour J., Leprince P., Dutour A., Clement K., Hatem S.N. Human epicardial adipose tissue induces fibrosis of the atrial myocardium through the secretion of adipo-fibrokines. Eur. Heart J. 2015, 36:795-805a.
59. Vilahur G., Badimon L. Ischemia/reperfusion activates myocardial innate immune response: the key role of the toll-like receptor. Front. Physiol. 2014, 5:496.
60. Wang T., Hu N., Cao J., Wu J., Su K., Wang P. A cardiomyocyte-based biosensor for antiarrhythmic drug evaluation by simultaneously monitoring cell growth and beating. Biosens. Bioelectron. 2013, 49:9-13.
61. Wei C.D., Li Y., Zheng H.Y., Tong Y.Q., Dai W. Palmitate induces H9c2 cell apoptosis by increasing reactive oxygen species generation and activation of the ERK1/2 signaling pathway. Mol. Med. Rep. 2013, 7:855-861.
62. Wu W., Lee W.L., Wu Y.Y., Chen D., Liu T.J., Jang A., Sharma P.M., Wang P.H. Expression of constitutively active phosphatidylinositol 3-kinase inhibits activation of caspase 3 and apoptosis of cardiac muscle cells. J. Biol. Chem. 2000, 275:40113-40119.
63. Zhang N., Liang H., Farese R.V., Li J., Musi N., Hussey S.E. Pharmacological TLR4 inhibition protects against acute and chronic fat-induced insulin resistance in rats. PLoS One 2015, 10:e0132575.